Function Health is an Aging Diagnostics & Biomarkers company founded in 2022 and based in Austin, United States. It has raised $350M in total funding, most recently a Series B in 2025 at a $2.5B valuation.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Nov 19, 2025 | Series B | $298M | $2.5B | Redpoint Ventures |
| Jun 25, 2024 | Series A | $53M | — |
| Andreessen Horowitz |

An opinion piece argues that the current valuations in consumer longevity can only be justified through aggressive M&A to own the full customer health relationship.

Function Health adds a connector linking members' biomarker data to Meta's personal AI agent Muse.
Function Health's core product is an annual membership that gives members more than 100 laboratory biomarker tests covering heart, hormone, metabolic, immune, and organ health, run twice yearly to build a longitudinal picture of their biology. Results are organized and explained in plain language, with flagged out-of-range markers and clinician oversight, so users can act on data that is normally fragmented across providers. The platform is designed to shift consumers from reactive sick-care toward continuous, data-driven preventive health.
Beyond blood testing, Function offers advanced whole-body MRI and CT scans to screen for structural disease early, integrating imaging with biomarker history in a single member record. Its Medical Intelligence Lab applies AI models to interpret combined lab and imaging data, surface risks, and generate personalized recommendations. Together these capabilities position Function as a comprehensive preventive-health platform aimed at detecting age-related disease before symptoms appear and tracking healthspan over time.